Medroxyprogesterone: here's the fair price
This is what US pharmacies pay, on average, for medroxyprogesterone. Use it to spot a fair cash price, and feel good about asking for one.
Medroxyprogesterone 2.5 Mg Tab
A fair cash price is usually this cost plus a dispensing fee. If your quote is many times higher, ask about a generic, another pharmacy, or a cash discount.
Ask for generic Medroxyprogesterone 2.5 Mg Tab. Pharmacies pay about $3.45 for 30. Ask your pharmacy for its cash price and compare it with your copay. A fair cash price is close to this cost plus a dispensing fee.
Source: CMS NADAC as of 2026-11-04. Ask your prescriber or pharmacist whether a generic is right for you.
Source: CMS NADAC weekly file as of 2026-11-04. Median across NDCs with the same description. Public domain.
Your ZIP and location stay in your browser. We never store them.
Every strength and form
| Product | Pharmacy cost | 30 count | Effective |
|---|---|---|---|
| MEDROXYPROGESTERONE 2.5 MG TABGeneric | $0.11 per tablet or capsule | $3.45 | 10/21/2026 |
| MEDROXYPROGESTERONE 5 MG TABGeneric | $0.14 per tablet or capsule | $4.18 | 10/21/2026 |
| MEDROXYPROGESTERONE 10 MG TABGeneric | $0.15 per tablet or capsule | $4.58 | 10/21/2026 |
| MEDROXYPROGESTERONE 150 MG/MLGeneric | $23.04 per mL | n/a | 10/21/2026 |
Source: CMS NADAC, as of 2026-11-04. National average acquisition cost, not a retail quote.
Label basics
What it is used for (FDA label)
INDICATIONS AND USAGE Medroxyprogesterone Acetate Tablets USP are indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer. They are also indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving daily oral conjugated estrogens 0.625 mg tablets.
Common side effects (FDA label)
ADVERSE REACTIONS See BOXED WARNINGS , WARNINGS , and PRECAUTIONS . Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The following adverse reactions have been reported in women taking medroxyprogesterone acetate tablets, without concomitant estrogens treatment: 1. Genitourinary system Abnormal uterine bleeding (irregular, increase, decrease), change in menstrual flow, breakthrough...
Warnings (from the label)
WARNINGS See BOXED WARNINGS . 1. Cardiovascular Disorders. An increased risk of PE, DVT, stroke, and MI has been reported with estrogen plus progestin therapy. Should any of these events occur or be suspected, estrogen plus progestin therapy should be discontinued immediately. Risk factors for arterial vascular disease (for example, hypertension, diabetes mellitus, tobacco use, hypercholesterolemia, and obesity) and/or venous thromboembolism (VTE) (for example, personal history or family history of VTE, obesity, and systemic lupus erythematosus) should be managed appropriately. a. Stroke In the WHI estrogen plus progestin substudy, a statistically significant increased risk of stroke was...
Source: FDA drug label via openFDA, label effective 2022-10-09. Full label on DailyMed. Excerpts are verbatim and truncated. Read the full label and ask your pharmacist.